US 9441225
Compositions and methods for inhibiting expression of factor V
granted A61KA61K47/554A61K48/00
Quick answer
US patent 9441225 (Compositions and methods for inhibiting expression of factor V) held by Alnylam Pharmaceuticals, Inc. expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K47/554, A61K48/00, A61P, A61P7/02